Henry Schein (HSIC) Lifted to “Strong-Buy” at BidaskClub

Henry Schein (NASDAQ:HSIC) was upgraded by equities researchers at BidaskClub from a “buy” rating to a “strong-buy” rating in a report issued on Thursday.

Other equities research analysts also recently issued research reports about the company. Robert W. Baird raised their price objective on Henry Schein from $83.00 to $90.00 and gave the company an “outperform” rating in a report on Tuesday, August 7th. Stifel Nicolaus raised their price objective on Henry Schein from $76.00 to $81.00 and gave the company a “hold” rating in a report on Tuesday, August 7th. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a report on Saturday, July 14th. Craig Hallum raised their price objective on Henry Schein from $83.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday, August 7th. Finally, Cleveland Research reissued a “hold” rating on shares of Henry Schein in a report on Monday, September 24th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $83.53.

NASDAQ HSIC opened at $83.00 on Thursday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.68 and a current ratio of 1.29. Henry Schein has a twelve month low of $62.56 and a twelve month high of $90.52. The firm has a market cap of $12.24 billion, a P/E ratio of 23.06, a PEG ratio of 2.48 and a beta of 0.97.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Monday, August 6th. The company reported $1.04 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.03. Henry Schein had a return on equity of 20.40% and a net margin of 3.15%. The company had revenue of $3.33 billion for the quarter, compared to the consensus estimate of $3.31 billion. During the same quarter last year, the business posted $0.88 EPS. Henry Schein’s revenue for the quarter was up 8.7% on a year-over-year basis. On average, analysts forecast that Henry Schein will post 4.12 earnings per share for the current fiscal year.

Large investors have recently made changes to their positions in the stock. NEXT Financial Group Inc bought a new position in shares of Henry Schein in the 3rd quarter worth about $103,000. McAdam LLC bought a new position in shares of Henry Schein in the 3rd quarter worth about $104,000. Squar Milner Financial Services LLC bought a new position in shares of Henry Schein in the 2nd quarter worth about $120,000. Piedmont Investment Advisors LLC bought a new position in shares of Henry Schein in the 2nd quarter worth about $130,000. Finally, Fuller & Thaler Asset Management Inc. raised its position in shares of Henry Schein by 57.1% in the 2nd quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock worth $160,000 after acquiring an additional 800 shares in the last quarter.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Story: Marijuana Stocks

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply